|Bid||0.00 x 1100|
|Ask||1,150.00 x 1300|
|Day's Range||1,294.06 - 1,294.06|
|52 Week Range||989.70 - 1,320.00|
|PE Ratio (TTM)||1,005.49|
|Forward Dividend & Yield||12.06 (0.93%)|
|1y Target Est||N/A|
Mallinckrodt (MNK) shares gained as the company beat both earnings and revenue estimates in the fourth quarter as Inomax sales revived somewhat.
When Baxter International Inc (NYSE:BAX) released its most recent earnings update (31 December 2017), I compared it against two factor: its historical earnings track record, and the performance of itsRead More...
Baxter International Inc (NYSE:BAX) files its latest 10-K with SEC for the fiscal year ended on December 31, 2017.
Today I will be providing a simple run-through of the discounted cash flows (DCF) method to estimate the attractiveness of Baxter International Inc (NYSE:BAX) as an investment opportunity. If youRead More...
Baxter International Inc on Thursday forecast 2018 earnings largely ahead of analysts' estimates and said it would continue to be active on the acquistion front and repurchase more shares through the year. "Any stock which had a guidance coming in-line or below has (seen) a negative reaction," Evercore ISI analyst Vijay Kumar told Reuters, adding that the same had happened to Intuitive Surgical Inc and Illumina Inc in January.
The Deerfield, Illinois-based company said it had a loss of 13 cents per share. Earnings, adjusted for non-recurring costs and to account for discontinued operations, came to 64 cents per share. The results ...
Baxter International Inc reported quarterly loss versus year-ago profit as the hospital products maker took a charge of $354 million due to changes in the U.S. tax law. Baxter posted net loss of $71 million, ...
As part of the amended tax policy, corporate tax rates are lowered to 21% from 35%, offering a huge relief to medical device giants.
Baxter International informed customers on Wednesday that it has been given approval by U.S. regulators to import large saline bags from its plant in Mexico in an effort to ease hospital shortages of the product as the nation faces a severe flu season. Supply issues related to Baxter's small-volume saline bags - which are produced in the U.S. market in Puerto Rico - have begun to ease as production there improves, Scott Luce, general manager of Baxter's U.S. Hospital products division, wrote in a letter addressed to customers and seen by Reuters.
Baxter International (BAX) is expected to gain from strength in Hospital Products segment on solid sales in the U.S. Fluid Systems business as well as growing demand for injectable pharmaceuticals.
This could indicate that investors who seek to profit from falling equity prices are not currently targeting BAX. BAX credit default swap spreads are within the middle of their range for the last three years.
Baxter's (BAX) Arisure Closed System reduces exposure risk of healthcare professionals to needles. Also, the latest development promotes safe handling of hazardous drugs.
Mallinckrodt's (MNK) strategy to streamline its business to evolve as a top-performing specialty pharmaceutical company has led the company to enter into an agreement to sell Recothrom and Preveleak to Baxter.
The U.S. is facing a nationwide shortage of intravenous bags because of production woes linked to the Puerto Rico hurricane, forcing many hospitals to use more time-consuming ways to administer drugs.
Baxter International Inc (NYSE:BAX) generated a below-average return on equity of 11.31% in the past 12 months, while its industry returned 13.25%. An investor may attribute an inferior ROE toRead More...
Baxter International shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 79 to 83.
The medical technology space for the most part benefited throughout 2017 and heading into 2018 some Wall Street analysts remain bullish. The Analyst JPMorgan's Michael Weinstein. The Thesis 2017 was a ...